 |
Synthetic double-stranded siRNA oligonucleotide directed against hydroxyacid oxidase 1 mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues |
|---|---|
| Trade Name | |
| Orphan Indication | Primary hyperoxaluria |
| EU Market Approval | EU |
| EU Designation Date | 2016-03-21 00:00:00 |
| Sponsor | Alnylam UK Limited |
